This message was sent to ##Email## To advertise in this publication please click here November 26, 2020 .INDUSTRY NEWS Double lung transplant patient with COVID-19 describes gasping for air WBUR-FM If more of us could see what frontline workers witness in the war against COVID-19 — people gasping for air and lungs shutting down — maybe more people would understand the seriousness of the disease. Thomas Steele has been there. The 50-year-old was healthy with no preexisting conditions, and he was working in sales at a New Braunfels, Texas, construction company when he contracted COVID-19. He didn’t worry about it too much, but then it got bad. He was hospitalized in San Antonio and placed on an ECMO machine, a last-ditch treatment that does the job of a patient’s heart or lungs by moving blood and oxygen. He was tethered to the machine for two months, but still his condition worsened. His lungs deteriorated so severely that he was transferred to Houston Methodist Hospital, where surgeon Dr. Thomas MacGillivray performed a double lung transplant that saved his life. READ MORE Informing the risk of kidney transplantation versus remaining on the wait list in the COVID-19 era Kidney International Reports There is limited data pertaining to comparative outcomes of remaining on dialysis versus kidney transplantation as the threat of COVID-19 remains. This study aims to delineate the differential risks involved using serological methods to help define exposure rates. READ MORE  SPONSORED VIDEO Kidney Transplant Patients and Immunosuppression Now you can see the different ways that different formulations are released and absorbed in the gastrointestinal system. You’ll also have the opportunity to explore comparative pharmacokinetic results in rapid metabolizers, efficacy data over 2 years, and safety information. WATCH VIDEO Acute kidney injury in deceased organ donors and kidney transplant outcomes Annals of Surgery The objective of this study was to determine graft function and survival for kidney transplants from deceased donors with acute kidney injury that persists at the time of organ procurement. READ MORE Expanding living donor liver transplantation: Report of first United States living donor liver transplant chain American Journal of Transplantation Living donor liver transplantation enjoys widespread use in Asia, but remains limited to a handful of centers in North America and comprises only five percent of liver transplants performed in the United States. In contrast, living donor kidney transplantation is used frequently in the United States, and has evolved to commonly include paired exchanges, particularly for ABO‐incompatible pairs. READ MORE  SPONSORED CONTENT Promoted by Natera National Kidney Foundation CME Course: Evaluation of Acute Allograft Rejection in Kidney Transplantation KDIGO Webinar: The Critical Role of Genetics in Kidney Disease NEW: The Renasight Genetic Panel Can Inform the Care Path for Patients Diagnosed with CKD Learn about Prospera for a Better Kidney Transplant Rejection Assessment Why Prospera is the Right Choice for Managing Transplant Recipients Remotely Prostate cancer: Overdiagnosis in solid organ transplant recipients Cancer Therapy Advisor Solid organ transplant recipients can have between a two to three times higher risk of developing certain cancers including non-Hodgkin lymphoma, colorectal cancer, lung cancer, and kidney cancer. This has led many physicians to alter their cancer screening protocols in SOTRs, including in prostate cancer, even though the data in this unique patient population are not as clear as they are in other malignancies. READ MORE Respiratory viral infections in solid organ transplant recipients American Journal of Transplantation Respiratory virus infections, a persistent source of morbidity and mortality for SOT recipients, have been best characterized in lung transplant recipients, in whom association with chronic lung allograft dysfunction has been reported. However, much less is known about clinical presentations and outcomes of RVI in non‐lung‐transplant SOT recipients. READ MORE  FEATURED ARTICLE   Support specialist for kidney transplantation Veloxis Pharmaceuticals Did you know there’s a transplant support system to help patients and providers with best-in-class assistance and resources? This ongoing support system assists with benefit investigation, prior authorization assistance, coordination with specialty pharmacies, prescription fulfillment navigation, and CoverMyMeds® access. There’s also a $0 co-pay card to overcome financial barriers. Find out more LEARN MORE   Letermovir and maribavir for the treatment and prevention of cytomegalovirus infection in solid organ and stem cell transplant recipients Clinical Infectious Diseases Until recently, available drugs for cytomegalovirus prevention and treatment in transplant patients included (val)ganciclovir, foscarnet, and cidofovir. Use of these drugs is limited by toxicity and the development of resistance. The 2017 approval of letermovir for prevention of CMV after stem cell transplant marked the first approval of an anti-CMV agent since 2003. READ MORE Comparative analysis of outcomes and long-term follow-up of robot-assisted pediatric kidney transplantation, with open counterpart Physician's Weekly How does the robotic kidney transplant fare against the open technique in pediatric patients? To address this question, this study compares the outcomes of robotic kidney transplants with those of open transplant in these patients. READ MORE   ITNS Insider Connect with ITNS Dennis Hall, Director of Publishing, MultiView, 469-420-2656 | Download media kit Anne Casey, Content Editor, MultiView, 469-420-2619 | Contribute news International Transplant Nurses Society 8735 W. Higgins Road, Suite 300 | Chicago, IL 60631 847-375-6340  |  Contact Us  |  www.itns.org Click here to unsubscribe.  Learn how to add us to your safe sender list so our emails get to your inbox. ADVERTISE SUBSCRIBE PAST ISSUES   7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063